Stock screener

PTGX

Conviction 82HealthcareScan · Thu, Sep 24, 2026

Protagonist Therapeutics, Inc (PTGX) closed at $137.28 (-1.03%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 37, RS Rating 94, -13.5% from its 52-week high, +57.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

PTGX$137.28-1.03%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 803.6K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Protagonist Therapeutics, IncPHARMACEUTICAL PREPARATIONSwww.protagonist-inc.com ↗
Price137.28
Change-1.03%
Gap+0.42%
Rel volume3.59×
Avg volume707.53K
Avg $ vol101.76M
SMA 20144.99
SMA 50144.40
SMA 200109.77
Price vs 50-4.93%
Price vs 200+25.06%
MA stackmixed
50/200 cross—
Supertrenddown · 152.55
RSI (14)37
MACD hist-1.14
MACD cross—
Stoch %K / %D18 / 22
ADX (14)16
+DI / −DI16 / 29
RSI divergence—
MACD divergenceBullish
ATR %3.87%
ADR %3.55%
52w high158.62
52w low64.00
From 52w high-13.46%
Above 52w low+114.49%
New 52w highNo
SqueezeOn · 6d
Bollinger width8.22%
%B-0.15
Donchian pos17.64%
Donchian high151.68
Donchian low134.19
AVWAP (52w high)145.67
vs AVWAP high-5.76%
AVWAP (52w low)100.64
vs AVWAP low+36.41%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d3.59×
Avg vol (14d)803.6K
Avg vol (20d)707.53K
Avg $ vol (20d)101.76M
Market cap8.88B
RS Rating94 / 99
RS 3m (vs SPY)+7.45%
RS 6m (vs SPY)+14.79%
RS line new highNo
Trend template7/8
Technical rank65.0
1 week-4.47%
1 month-8.84%
3 months+11.94%
6 months+31.60%
1 year+111.00%
YTD+57.46%
P/E-68.25
P/B10.56
P/S—
P/FCF158.39
EPS-2.05
Div yield—
ROE-15.47%
ROA-14.70%
Debt/Eq0.01
Current21.71
EV/EBITDA-54.02
Gross margin—
Net margin—
Rev growth—
EPS growth-147.29%
Price target167.00
Target upside21.65%
Analyst ratingBuy
Institutional130.23%
Ent. value8.47B
Revenue213.47M
Net income162.85M
Gross profit—
Free cash flow56.08M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out64.31M
Employees131
ListedThu, Aug 11, 2016
Free float59.71M
Float %93.6%
Short interest7.71M
Days to cover15.3d
Short volume61.9%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.29 vs $2.11
Last surprise+8.5% beat
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank65.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance159.45
Support141.46
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PTGX

All disclosures →
No recent disclosed trades by Congress in PTGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PTGX · open-market 3 sells

InsiderSideShares
PATEL DINESH V PH D
President and CEO · Common Stock · 2026-08-11
Exercise34.24K
PATEL DINESH V PH D
President and CEO · Common Stock · 2026-08-11
Sell34.24K
PATEL DINESH V PH D
President and CEO · Stock Option (right to buy) · 2026-08-11
Exercise34.24K
PATEL DINESH V PH D
President and CEO · Common Stock · 2026-08-10
Sell65.76K
PATEL DINESH V PH D
President and CEO · Common Stock · 2026-08-10
Exercise65.76K
PATEL DINESH V PH D
President and CEO · Stock Option (right to buy) · 2026-08-10
Exercise65.76K
Waddill William D.
Director · Common Stock · 2026-06-23
Exercise9K
Waddill William D.
Director · Common Stock · 2026-06-23
Sell9K
Waddill William D.
Director · Stock Option (right to buy) · 2026-06-23
Exercise9K
Waddill William D.
Director · Common Stock · 2026-05-29
Exercise9K

SEC filings

EDGAR filings in PTGX · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.